- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 4th, 2005
When companies partner with one another, it is with the expectation that each has a role to play. Each is expected to perform its part conscientiously and expeditiously. When one partner doesn't hold up its end of the bargain, it results in delays, lost opportunities and, most importantly for companies, lost revenues.
Such is the case with the just-severed deal between pharmaceutical Biovail and nanotech developer Flamel.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
Meteorite impact on a nano scale August 29th, 2016